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Background: Microalbuminuria and obesity markers are known risk factors for cardiovascular or renal disease. 
This study aimed to evaluate the prevalence of microalbuminuria according to body mass index (BMI) and ab-
dominal obesity criteria.
Methods: The study subjects included 3,979 individuals aged 30 years or older who did not have diabetes, hyper-
tension, renal failure, or overt proteinuria, from among those who participated in The Korean National Health and 
Nutrition Examination Survey in 2013, a cross-sectional, nationally representative, stratified survey. Microalbumin-
uria was defined as a urinary albumin to creatinine ratio of 30 to 300 mg/g. BMI and waist circumference were clas-
sified according to the Asia-Pacific criteria.
Results: The prevalence of microalbuminuria was found to be 5.1%. In the normoalbuminuria group, 3.4%, 41.7%, 
24%, 27.6%, and 3.2% of participants were included in the underweight, normal, overweight, obesity 1, and obesity 
2 groups, respectively. These percentages in the microalbuminuria group were 7.1%, 34.5%, 19.2%, 28.6%, and 10.6%, 
respectively (P<0.001). The waist circumference in men was 21.4% in the normoalbuminuria group and 36.5% in 
the microalbuminuria group (P=0.004). Logistic regression analyses were performed to evaluate the relationship 
between the presence of microalbuminuria and BMI or waist circumference groups. The risk of microalbuminuria 
was significant only in the underweight group (odds ratio, 13.22; 95% confidence interval, 2.55–68.63; P=0.002) af-
ter adjusting for confounding factors, abdominal obesity was not significantly associated with microalbuminuria.
Conclusion: The prevalence of microalbuminuria in a general population in Korea was associated with underwei-
ght in men and was not associated with waist circumference in either men or women.
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INTRODUCTION
Microalbuminuria is among the strongest predictors of both 
diabetic nephropathy and cardiovascular disease outcomes in 
patients with type 2 diabetes mellitus or hypertension.1,2) The 
early detection of microalbuminuria is important in the gener-
al population as well3) because studies have shown that micro-
albuminuria is independently associated with an increase in 
the prevalence and mortality from cardiovascular disease.4)
 Microalbuminuria is considered to be an indicator of a poor 
renal prognosis because it is associated with hemodynamic 
adaptations of glomerular hypertension and hyperfiltration in 
remnant nephrons due to glomerular permeability dysfunc-
tion, which ultimately proves detrimental.5) Glomerular albu-
min leakage is considered to reflect widespread atherosclero-
sis-mediated capillary vasculopathy or dysfunction of the co-
agulation and fibrinolytic systems.6)
 Several studies have shown that risk factors associated with 
microalbuminuria include age, systolic blood pressure, fasting 
serum glucose, body mass index, waist circumference (WC), 
visceral fat, insulin resistance, malnutrition, chronic inflamma-
tion as well as diabetes mellitus, hypertension, and chronic kid-
ney disease.2,7-14) However, studies on the general population 
are lacking.
 Abdominal obesity is found to be more strongly associated 
with microalbuminuria rather obesity in general,2,8) and WC 
and body mass index (BMI) have been frequently used as obe-
sity indices in assessing the relationship between obesity and 
microalbuminuria, because these variables are easy to mea-
sure.15,16)
 The aim of the current study was to examine the association 
of BMI and WC with the prevalence of microalbuminuria in 
Korean adults aged 30 years and older who did not have diabe-
tes, hypertension, renal failure, or overt proteinuria by using 
The Korean National Health and Nutrition Examination Survey 
(KNHANES) of 2013.
METHODS
1. Sample
This study included 3,979 individuals aged 30 years or older 
who did not have overt proteinuria (i.e., urine albumin to cre-
atinine ratio >300 mg/g), diabetes (diagnosed or being treat-
ed), hypertension, or renal failure, from among 8,018 individu-
als who participated in The KNHANES VI-1 in 2013, a cross-sec-
tional, nationally representative, and stratified survey.
2. Physical Measurements and Clinical Examination
Height was measured to the nearest 1 mm using a stadiometer 
(SECA 255; SECA, Hamburg, Germany). Weight was measured 
to the nearest 0.1 kg using GL-6000-20 (G-tech, Seoul, Korea).17) 
BMI was calculated by dividing weight by the square of height 
(kg/m2). WC was measured to the nearest 1 mm using SECA 
200 (SECA) by palpating the two points of the upper portion of 
the iliac ridge and the lower end of the rib when the study sub-
jects breathed out.17) Abdominal obesity was defined using the 
Asia-pacific criteria.18)
 Blood samples were collected in the morning after fasting for 
at least 8 hours to measure fasting plasma glucose, hemoglobin 
A1c (HbA1c), total cholesterol, high density lipoprotein (HDL) 
cholesterol, low density cholesterol (LDL) cholesterol, triglyc-
erides, serum creatinine, and blood urea nitrogen using ADIV-
IA650 (Siemens, Madison, WI, USA).17)
 Single-spot urine specimens were collected (20–30 mL of 
midstream voided urine). The ratio of urinary albumin to uri-
nary creatinine, measured using Hitachi 7600 (Hitachi, Tokyo, 
Japan),17) was reported as urinary albumin-to-creatinine ratio 
(UACR, mg/g).
 Blood pressure (BP) was measured by standard methods us-
ing a sphygmomanometer after the subject rested for 5 min-
utes in the sitting position. Three measurements were taken for 
each subject at 30-second intervals; the average of the second 
and third measurements was used in the analysis.17)
 The estimated glomerular filtration rate (eGFR) was calcu-
lated by the researcher using the Modification of Diet in Renal 
Disease study equation.19)
3. Definitions
Microalbuminuria was defined as a UACR of 30 to 300 mg/g. 
The subjects were categorized as having normoalbuminuria 
(UACR <30 mg/g) or microalbuminuria (UACR 30–300 mg/g). 
Baseline characteristics were compared between the two groups. 
These included age, sex, body weight, BMI, obesity, WC, sys-
tolic BP, diastolic BP, fasting plasma glucose, HbA1c, total cho-
lesterol, HDL cholesterol, triglycerides, LDL cholesterol, blood 
urea nitrogen, and eGFR.
 Body weight was classified according to BMI as underweight 
(BMI<18.5 kg/m2), normal (18.5≤BMI<23.0), overweight (23.0 
≤BMI <25.0), obesity 1 (25.0 ≤BMI <30.0), or obesity 2 (BMI 
≥30.0) according to Asia-Pacific obesity criteria. WC was cate-
gorized as follows: WC <90 cm and WC ≥90 cm for male par-
ticipants and WC <80 cm and WC ≥80 cm for female partici-
pants.20)
4. Statistical Analysis
The KNHANES VI-1 had a complex sample design, which in-
cluded a primary extraction unit, multistage stratification, and 
weighted values to minimize selection bias. To compare base-
line characteristics between albuminuria categories, means 
with standard errors of the mean or standard deviations were 
extracted using the independent t-test for continuous variables. 
The chi-square test was used to extract ratios for categorical 
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variables.
 The presence of normoalbuminuria or microalbuminuria 
was used as the binary dependent variable. The 5 BMI (under-
weight, normal, overweight, obesity 1, and obesity 2) and 2 WC 
categories were used as independent variables. Multiple logis-
tic regression analyses were performed to analyze the associa-
tion between microalbuminuria and each dependent variable 
after adjustment for various confounding variables (those found 
to be associated with microalbuminuria in previous studies). 
All analyses were performed using IBM SPSS ver. 20.0 (IBM Co., 
Armonk, NY, USA). Statistical significance was set at P<0.05.
RESULTS
Of the 3,979 participants considered for inclusion in the study, 
3,257 had a UACR of less than 300 mg/g and were included in 
the final analysis. Of these, 3,091 participants (94.9%) had nor-
moalbuminuria and 166 (5.1%) had microalbuminuria. Age, 
obesity, systolic BP, diastolic BP, fasting plasma glucose, HbA1c, 
total cholesterol, triglycerides, serum creatinine, and eGFR were 
significantly different between the two groups, whereas body 
weight, BMI, WC, HDL cholesterol, and blood urea nitrogen 
were not significantly different. In the normoalbuminuria group, 
3.4%, 41.7%, 24%, 27.6%, and 3.2% of participants were includ-
ed in the underweight, normal, overweight, obesity 1, and obe-
sity 2 groups, respectively, while these percentages were 7.1%, 
34.5%, 19.2%, 28.6%, and 10.6%, respectively, in the microalbu-
minuria group (P<0.001). The prevalence of abdominal obesi-
ty was significantly different between the normoalbuminuria 
and microalbuminuria groups for men (21.4% versus 36.5%, 
P=0.004), although there was no significant difference for wo-
men (Table 1).
 In multiple logistic regression analyses, the normal BMI group 
was used as reference. The risk of microalbuminuria was sig-
nificantly increased in the underweight and obesity 2 groups 
(odds ratio [OR], 2.49; 95% confidence interval [CI], 1.28–4.83; 
P=0.007 for the underweight group; OR, 4.01; 95% CI, 1.95–8.21; 
P<0.001 for the obesity 2 group). After adjusting for age and sex 
(model 2), the risk of microalbuminuria was still significantly 
increased in the underweight and obesity 2 groups (OR, 2.41; 
95% CI, 1.22–4.77; P=0.010 for the underweight group; OR, 4.01; 
95% CI, 1.95–8.21; P <0.001 for the obesity 2 group). After ad-
justing for fasting plasma glucose, HbA1c, systolic BP, diastolic 
BP, triglycerides, total cholesterol, and WC in model 2 (model 
Table 1. Baseline characteristics and BMI and WC categories in each albuminuria group
Characteristic Normoalbuminuria (n = 3,091) Microalbuminuria (n = 166) P-value
Age (y) 49.5±12.9 54.3±15.0 0.003
Female (%)* 55.5 56.6 0.770
Body weight (kg) 64.2±0.3 65.3±1.4 0.410
Body mass index (kg/m2)
   < 18.5*
   18.5–22.9*
   23–24.9*
   25–29.9*
   ≥ 30*
23.7±0.1
  3.4
41.7
24.0
27.6
  3.2
24.2±0.4
  7.1
34.5
19.2
28.6
10.6
0.170
< 0.001
Obesity* 30.8 39.2 0.030
Waist circumference (cm) 80.3±0.2 82.1±1.0 0.070
Male
   < 90*
   ≥ 90*
78.6
21.4
63.5
36.5
0.004
Female
   < 80*
   ≥ 80*
64.7
35.3
63.1
36.9
0.450
Blood pressure (mm Hg)
   Systolic blood pressure
   Diastolic blood pressure
115.0±0.3
75.8±0.3
125.9±1.8
81.4±1.3
< 0.001
< 0.001
Fasting plasma glucose (mg/dL) 96.4±0.3 104.5±2.8 0.004
Hemoglobin A1c (mean %) 5.8±0.0 5.9±0.1 0.041
Lipid profile (mg/dL)
   Total cholesterol
   High density lipoprotein cholesterol
   Triglyceride
   Low density lipoprotein cholesterol
191.5±0.7
52.2±0.3
137.8±2.5
115.7±1.7
201.5±3.7
53.1±1.1
178.0±15.2
123.8±6.5
0.006
0.450
0.010
0.210
Blood urea nitrogen (mg/dL) 13.9±0.1 13.9±0.4 0.990
Serum creatinine (mg/dL) 0.8±0.0 0.8±0.0 0.033
Estimated glomerular filtration rate† (mL/min/1.73 m2) 93.6±0.4 97.5±1.7 0.025
Values are presented as mean± standard error (except for age, mean± standard deviation) or %. P-values were calculated using the independent t-test.
*P-values were calculated using the chi-square test. †Calculated using the Modification of Diet in Renal Disease equation.
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3), the risk of microalbuminuria was significantly increased in 
only the underweight group (OR, 3.82; 95% CI, 1.62–9.02; P = 
0.002) (Table 2).
 For male subjects alone, the risk of microalbuminuria was 
significantly increased in the underweight and obesity 2 groups 
in multiple logistic analyses (OR, 5.15; 95% CI, 1.66–16.01; P= 
0.005 for the underweight group; OR, 5.93; 95% CI, 2.22–15.88; 
P<0.001 for the obesity 2 group). After adjusting for age (model 
2), the risk of microalbuminuria was still significantly increased 
in the underweight and obesity 2 groups (OR, 4.33; 95% CI, 1.40–
13.41; P =0.010 for the underweight group; OR, 7.02; 95% CI, 
2.49–19.76; P<0.001 for the obesity 2 group). After adjusting for 
age, fasting plasma glucose, HbA1c, systolic BP, diastolic BP, tri-
glycerides, total cholesterol, and WC (model 3), the risk of mi-
croalbuminuria was significantly increased in only the under-
weight group (OR, 13.22; 95% CI, 2.55–68.63; P=0.002) (Table 3).
 On the other hand, for female subjects alone, the risk of mi-
croalbuminuria was not significantly increased in the under-
weight, obesity 1, or obesity 2 group, compared with the nor-
mal BMI group (OR, 1.65; 95% CI, 0.67–4.09; P =0.280 for the 
underweight group; OR, 1.05; 95% CI, 0.58–1.91; P =0.860 for 
the obesity 1 group; OR, 2.59; 95% CI, 0.96–7.04; P =0.060 for 
the obesity 2 group). After adjusting for confounding factors, 
the risk of microalbuminuria was not significantly increased in 
either model 2 or model 3 (Table 4).
 When multiple logistic regression analysis was performed to 
Table 2. ORs for microalbuminuria in each BMI category, with the normal weight category (18.5 ≤ BMI < 23.0) used as reference
BMI category*
Model 1† Model 2‡ Model 3§
OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value
Underweight 2.49 (1.28–4.83) 0.007 2.41 (1.22–4.77) 0.010 3.82 (1.62–9.02) 0.002
Normal weight 1.00 - 1.00 - 1.00 -
Overweight 0.97 (0.58–1.62) 0.900 0.93 (0.56–1.54) 0.770 0.82 (0.48–1.41) 0.460
Obesity 1 1.25 (0.82–1.92) 0.300 1.24 (0.80–1.92) 0.330 0.81 (0.45–1.48) 0.490
Obesity 2 4.01 (1.95–8.21) < 0.001 4.29 (2.10–8.80) < 0.001 2.41 (0.70–8.27) 0.160
P-values were calculated using logistic regression analyses.
OR, odds ratio; BMI, body mass index; CI, confidence interval.
*Underweight, BMI < 18.5; normal weight, 18.5 ≤ BMI < 23.0; overweight, 23.0 ≤ BMI < 25.0; obesity 1, 25.0 ≤ BMI < 30.0; obesity 2, BMI > 30.0. †Model 1: no adjustments. 
‡Model 2: adjusted for age and sex. §Model 3: adjusted for age, sex, fasting plasma glucose, hemoglobin A1c, systolic blood pressure, diastolic blood pressure, triglycerides, 
total cholesterol, and waist circumference.
Table 3. ORs for microalbuminuria in each BMI category for men, with the normal weight category (18.5 ≤ BMI < 23.0) used as reference
BMI category*
Model 1† Model 2‡ Model 3§
OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value
Underweight   5.15 (1.66–16.01) 0.005   4.33 (1.40–13.41) 0.010 13.22 (2.55–68.63) 0.002
Normal weight 1.00 -¶ 1.00 - 1.00 -
Overweight 1.15 (0.52–2.52) 0.730 1.16 (0.53–2.55) 0.710 1.06 (0.45–2.51) 0.900
Obesity 1 1.54 (0.77–3.09) 0.220 1.69 (0.80–3.54) 0.170 0.85 (0.29–2.45) 0.760
Obesity 2   5.93 (2.22–15.88) < 0.001   7.02 (2.49–19.76) < 0.001   2.18 (0.33–14.65) 0.420
P-values were calculated using logistic regression analyses.
OR, odds ratio; BMI, body mass index; CI, confidence interval.
*Underweight, BMI < 18.5; normal weight, 18.5 ≤ BMI < 23.0; overweight, 23.0 ≤ BMI < 25.0; obesity 1, 25.0 ≤ BMI < 30.0; obesity 2, BMI > 30.0. †Model 1: no adjustments. 
‡Model 2: adjusted for age. §Model 3: adjusted for age, fasting plasma glucose, hemoglobin A1c, systolic blood pressure, diastolic blood pressure, triglycerides, total cholesterol, 
and waist circumference.
Table 4. ORs for microalbuminuria in each BMI category for women, with the normal weight category (18.5 ≤ BMI < 23.0) used as reference
BMI category*
Model 1† Model 2‡ Model 3§
OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value
Underweight 1.65 (0.67–4.09) 0.280 1.67 (0.67–4.17) 0.270 1.95 (0.66–5.74) 0.230
Normal weight 1.00 -¶ 1.00 - 1.00 -
Overweight 0.87 (0.41–1.87) 0.720 0.80 (0.37–1.73) 0.560 0.68 (0.29–1.59) 0.370
Obesity 1 1.05 (0.58–1.91) 0.860 0.93 (0.51–1.69) 0.800 0.80 (0.39–1.65) 0.540
Obesity 2 2.59 (0.96–7.04) 0.060 2.48 (0.88–7.01) 0.090   2.27 (0.48–10.74) 0.300
P-values were calculated using logistic regression analyses.
OR, odds ratio; BMI, body mass index; CI, confidence interval.
*Underweight, BMI < 18.5; normal weight, 18.5 ≤ BMI < 23.0; overweight, 23.0 ≤ BMI < 25.0; obesity 1, 25.0 ≤ BMI < 30.0; obesity 2, BMI > 30.0. †Model 1: no adjustments. 
‡Model 2: adjusted for age. §Model 3: adjusted for age, fasting plasma glucose, hemoglobin A1c, systolic blood pressure, diastolic blood pressure, triglycerides, total cholesterol, 
and waist circumference.
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determine the risk of microalbuminuria in the abdominal obe-
sity group compared to the normal WC group in male subjects, 
the OR was 2.12 (95% CI, 1.19–3.77; P =0.010). In female sub-
jects on the other hand, the risk of microalbuminuria was not 
significantly increased in multiple logistic regression analysis. 
In men, after adjusting for age, the result was still significant 
(OR, 2.16; 95% CI, 1.21–3.87; P =0.010). However, in women, 
the OR decreased to 1.02 after adjusting for age (95% CI, 0.61–
1.72; P =0.930) and was no longer significant. After adjusting 
for confounding factors, the risk of microalbuminuria was not 
significant in either men or women (Table 5).
DISCUSSION
This study aimed to identify the association of BMI and WC 
categories with the prevalence of microalbuminuria in Korean 
adults aged 30 years or older who did not have diabetes, hyper-
tension, renal failure, or over proteinuria and participated in 
The KNHANES in 2013. The BMI category of underweight was 
found to be an independent risk factor for the presence of mi-
croalbuminuria in men.
 A previous study showed that microalbuminuria might be 
associated with abdominal obesity in non-diabetic, non-hy-
pertensive men who attended a Korean health care center.8) 
Another study showed that abdominal obesity rather than over-
all obesity was an independent risk factor for microalbumin-
uria.2)
 In men, the proportion of participants with abdominal obe-
sity was significantly different between the normoalbuminuria 
and microalbuminuria groups (21.4% vs. 36.5%). The risk of 
microalbuminuria was higher in abdominal obesity group than 
in the normal WC group in the logistic analyses before adjust-
ments in men. Thus, a positive correlation could exist between 
abdominal obesity and microalbuminuria, partially confirming 
the results of previous studies.
 Several studies have reported positive correlations between 
underweight and microalbuminuria both in Korea and in other 
countries. A possible explanation is that, since underweight is 
associated with a low muscle mass, the excretion of urinary cre-
atinine is decreased, thereby resulting in an increased risk of 
microalbuminuria.12,21)
 A Japanese study reported a U-shaped association between 
BMI and proteinuria. Postural proteinuria is suggested to be 
associated with renal ptosis or wandering kidney, which is of-
ten found in thin people, and it increases the prevalence of mi-
croalbuminuria in underweight individuals.15) A small nephron 
number increases the risk of hyperfiltration; thus, it might re-
sult in proteinuria because underweight individuals may have 
had a low birth weight as well.22,23)
 The term ‘malnutrition inflammation complex syndrome’ 
has been used for patients diagnosed with end-stage renal dis-
ease because malnutrition has been found to be closely associ-
ated with an inflammatory reaction in these patients.13)
 Serum albumin, total iron binding capacity, and BMI are 
commonly used markers of nutritional status,13) and the C-re-
active protein level is often employed as a marker of inflamma-
tion. The associations between these factors and cardiovascu-
lar disease have been investigated in several studies.24-26)
 A low BMI might reflect low muscle mass. A reduced muscle 
mass in turn might trigger an inflammatory reaction, resulting 
in an increase in the levels of inflammatory markers such as in-
terleukin-6 or C-reactive protein27) or coronary heart disease.21,28) 
Although fat might be expected to decrease during weight loss, 
visceral fat is not easily lost, whereas muscle mass and water 
content decreases more easily in humans.29) Thus, the under-
weight BMI group could be affected by inflammatory reactions 
of visceral fat and have a decreased muscle mass, thus explain-
ing the high risk of microalbuminuria in this group in this study.
 In this current study, there was definite gender-related dif-
ference in the risk of microalbuminuria according to BMI cate-
gory. This result might be associated with the fact that men are 
more likely to have more visceral fat than other fat components 
whereas women are more likely to have more subcutaneous fat 
than other fat components, due to hormonal differences.30)
 Adiponectin, which is secreted by adipocytes, is an anti-ath-
erosclerotic, anti-inflammatory substance, and its secretion is 
decreased with an increase in visceral fat, resulting in an increase 
in the prevalence of cardiovascular disease. The greater the 
proportion of visceral fat in the body, the higher the level of in-
flammatory substances secreted; this adversely affects blood 
Table 5. ORs for microalbuminuria according to WC (with < 90 cm used as reference for men and < 80 cm used as reference for women)
WC category
Model 1* Model 2† Model 3‡
OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value
Male WC < 90 cm
WC ≥ 90 cm
1.00
2.12 (1.19-3.77)
-
0.010
1.00
2.16 (1.21-3.87)
-
0.010
1.00
1.56 (0.71-3.44)
-
0.270
Female WC < 80 cm
WC ≥ 80 cm
1.00
1.21 (0.74-1.97)
-
0.450
1.00
1.02 (0.61-1.72)
-
0.930
1.00
0.81 (0.42-1.57)
-
0.530
P-values were calculated using logistic regression analyses.
OR, odds ratio; WC, waist circumference; CI, confidence interval.
*Model 1: no adjustments. †Model 2: adjusted for age. ‡Model 3: adjusted for age, fasting plasma glucose, hemoglobin A1c, systolic blood pressure, diastolic blood pressure, 
triglycerides, total cholesterol, and body mass index.
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vessels and insulin action, and increases the risk of cardiovas-
cular disease.7,31) The male subjects in the underweight group 
in this study might have had the most severe inflammatory re-
action because of the relatively decreased muscle mass and in-
creased proportion of visceral fat, thus increasing the preva-
lence of microalbuminuria.
 According to the statistical data of KHANES VI-1 (2013), the 
rate of subjectively recognizing obesity and the proportion of 
individuals trying to lose weight are showing an increasing 
trend.17) This is encouraging on the one hand because the prev-
alence of obesity is estimated to be 30% in Korea. On the other 
hand however, the results of this study indicated that excessive 
weight loss have an adverse effect on health. Therefore, a bal-
anced diet, an increase in muscle mass, and a decrease in fat 
would be more important than unconditional excessive weight 
loss.
 Because of its cross-sectional design, this study did not allow 
the investigation of causality in the association between micro-
albuminuria and malnutrition. However, this study is valuable 
because of the early results indicating an association between 
microalbuminuria and underweight in a general population 
aged 30 years or older in a representative sample of the Korean 
population. Further studies that include an analysis of the se-
rum albumin level, C-reactive protein level, and body fat ratio, 
which are relatively easy to evaluate, are expected to be under-
taken in the future.
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